Clinical Trials
Edible Sensor Monitors HIV Patients Antiretroviral Doses
A new ingestible sensor system that was put to the test in an interventional clinical trial gave HIV patients real-time antiretroviral dosage information, helping them to better manage their infection.
The Proteus Digital Health Feedback (PDHF) information technology system kept...
Drug Research
In Britain, The ABPI Sets Out A Clear Antimicrobial Goal
The Association of the British Pharmaceutical Industry (ABPI) has reemphasized its message to the industry about the development of new antibiotics on the eve of World Antibiotic Awareness Week.
Antibiotic-resistant illnesses are thought to have caused 1.2 million deaths...
News
Oxford Scientists Have Found Main Origin of Type 2 Diabetes
The root cause of type 2 diabetes has been clarified by a new study, which shows that elevated blood glucose alters the metabolism of pancreatic cells.
Approximately 415 million people worldwide have diabetes. Nearly five million people in the UK...
Drug Research
First Implanted Pump Uses Chemotherapy To Treat Brain Cancer
In a Phase I study that was recently published in the journal Lancet Oncology, it was shown that the first implantable pump system for individuals suffering from brain cancer could successfully kill reoccurring glioblastoma (GBM) tumour cells by continuously...
News
Research Brings Hope To Neurodegenerative Disease Sufferers
The development of a neurodegenerative disease in mice is slowed down by a novel therapy, according to researchers. The ground-breaking study may provide hope for treating conditions like Alzheimer's Disease (AD), which is regarded as incurable.
Researchers at the University of...
News
NHS Should Not Employ 5 COVID Therapies, According To NICE
Five COVID-19 therapies, including Merck & Co.'s antiviral tablet for high-risk patients, have been recommended for discontinuation by Britain's agency that decides whether medications may be used in the National Health Service (NHS), citing cost-effectiveness issues.
As the pandemic moves...
Drug Research
IGBA- 2022 WHO Biosimilar Roadmap Facilitates Accessibility
According to the new whitepaper Embracing Science with Confidence: Adopting the Revised 2022 WHO Biosimilars Guideline from the International Generic and Biosimilar Medicines Association (IGBA), the framework provides a fantastic opportunity to re-evaluate how regulatory standards can better progress...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.